Edwards Lifesciences (EW) Net Cash Flow Growth (5y) (2014 - 2026)
Edwards Lifesciences (EW) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.29 Bn | 123.81 Bn | 4.50 Bn |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.14 Bn | 72.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.68 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.19 Bn | 18.78 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.21% |
| Mar 31, 2026 | -84.34% |
| Dec 31, 2025 | 5.88% |
| Sep 30, 2025 | -46.72% |
| Jun 30, 2025 | -6.98% |
| Mar 31, 2025 | 17.18% |
| Dec 31, 2024 | -162.70% |
| Sep 30, 2024 | 35.24% |
| Jun 30, 2024 | 79.42% |
| Mar 31, 2024 | 85.23% |
| Dec 31, 2023 | 13.63% |
| Sep 30, 2023 | 62.63% |
| Jun 30, 2023 | 104.12% |
| Mar 31, 2023 | -23.51% |
| Dec 31, 2022 | -35.11% |
| Sep 30, 2022 | -20.55% |
| Jun 30, 2022 | 20.02% |
| Mar 31, 2022 | 27.61% |
| Dec 31, 2021 | -33.78% |
| Sep 30, 2021 | -6.69% |